News
The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL) is pleased to announce that Dr. Paul Collins has recently joined the Institute as a NIIMBL Senior Fellow. Paul will lead the NIIMBL-led Process Intensification (PI) Program.
“We are very excited to have Paul’s experience and enthusiastic leadership of the PI Program...
The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL ) is pleased to announce Project Call 10.1 for technology and workforce development projects. NIIMBL expects to launch a combined $8 million of project activities to address U.S. competitiveness in biopharmaceutical manufacturing.
Concept submissions are due...
NIIMBL’s Viral Vector Program has selected eight teams to participate in an interlaboratory study focused on improving the accuracy of AAV9 capsid titer measurements. The goal is to enhance consistency in manufacture of gene therapy products.
The selected teams are:
Carnegie Mellon University Keck Graduate Institute Landmark Bio Michigan...